Who is this EPA relevant to?
Trainees, supervisors of training (SOTs), fellows, clinical supervisors multidisciplinary team members and assessors involved in complex pain formulation.
What evidence could be included?
View the draft of EPA 3
This guideline relates to entrustable professional activity 3 (EPA 3), which focuses on the synthesis and application of a comprehensive sociopsychobiomedical framework to evaluate and manage patients experiencing pain.
Other pages you might be interested in
This EPA focuses on the trainee’s ability to conduct a comprehensive assessment of a patient with complex pain, bringing together clinical information, patient history, risk, context and professional judgement.
This EPA focuses on safe pharmacotherapy practice, including prescribing, supervising and tapering analgesic medicines in coordination with other prescribers.
This EPA focuses on the trainee’s ability to develop, communicate and review a pain management plan that is safe, patient-centred, practical and coordinated with relevant members of the care team.